<DOC>
	<DOCNO>NCT01814085</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety escitalopram treatment participant severe major depressive disorder ( MDD [ mark depression appear involution period characterize hallucination , delusion , paranoia , agitation ] ) .</brief_summary>
	<brief_title>A Safety Efficacy Study Escitalopram Acute Treatment Severe Depression</brief_title>
	<detailed_description>This single-arm ( clinical study one group participant ) , open-label ( people know identity intervention ) , multi-center ( one hospital medical school team work medical research study ) , prospective ( study follow participant forward time ) study . The study consist 2 part : Screening ( , 5 day study commences Day 1 ) Treatment ( , Week 1-8 ) . All eligible participant receive flexible dos escitalopram orally dose range 10 20 milligram per day ( mg/day ) 8 week . Efficacy primarily evaluate remission rate end study . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Participants diagnose major depressive disorder ( MDD ) accord Diagnostic Statistical Manual Mental DisordersIV ( DSMIV ) Scores great equal 30 MontgomeryAsberg Depression Rating Scale ( MADRS ) Pregnant lactate female participant Participants previously currently diagnose follow mental disorder DSMIV : organic mental disorder , schizophrenia ( psychiatric disorder symptom emotional instability , detachment reality , often delusion hallucination , withdrawal self ) , schizoaffective disorder , delusional disorder , undifferentiated mental disorder bipolar affective disorder , participant history drug abuse , include alcohol drug abuse past 12 month Participants significant risk suicide clinical assessment ( score great equal 5 item 5 MADRS ) make serious suicide attempt within past 6 month contraindication escitalopram Participants know history serious unstable medical illness , include cardiovascular , hepatic , renal , respiratory , endocrine , neurologic hematologic disease currently take psychotropic drug anticonvulsant agent continuously take benzodiazepine sleep pill five day past one week Participants history seizure ( sudden , uncontrolled muscle spasm loss consciousness result abnormal brain function ) disorder , brain injury , history know neurological disease ( multiple sclerosis , degenerative disease , parkinson disease movement disorder ) multiple drug adverse reaction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Escitalopram</keyword>
	<keyword>Lexapro</keyword>
</DOC>